Related Experiment Videos
The causes of interstitial pneumonitis in immunocompromised children: an aggressive systematic approach to diagnosis
Insights
Early diagnosis and aggressive treatment of interstitial pneumonitis in immunocompromised children improve survival rates. Prompt lung biopsy and analysis are crucial for identifying the cause and guiding therapy.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Oncology
Background:
- Interstitial pneumonitis poses a significant threat to immunocompromised children.
- Early recognition of symptoms and signs is critical for timely intervention.
Purpose of the Study:
- To evaluate the efficacy of a systematic, aggressive diagnostic and therapeutic approach for interstitial pneumonitis in immunocompromised children.
- To identify prognostic factors influencing survival in this patient population.
Main Methods:
- A cohort of 24 immunocompromised children with interstitial pneumonitis underwent an aggressive diagnostic workup.
- Open lung biopsy was performed, with tissue analyzed by impression smears, sections, and cultures.
- Emphasis was placed on parent and physician awareness of early symptoms.
Main Results:
- The etiologic agent was identified in 21 of 24 patients within three hours using stained impression smears.
- Eighteen of 24 patients survived the illness.
- Poor prognosis was associated with the need for ventilatory support and prolonged respiratory symptoms prior to biopsy.
- Children with solid tumors, low lymphocyte counts, and prior chest radiation developing Pneumocystis carinii pneumonitis had a uniformly fatal outcome.
Conclusions:
- A systematic, aggressive approach including early diagnosis and prompt lung biopsy significantly improves outcomes for immunocompromised children with interstitial pneumonitis.
- Identifying the causative agent rapidly via impression smears is feasible and aids in treatment.
- Prognostic factors such as ventilatory support, symptom duration, and specific patient characteristics (e.g., solid tumors, prior treatment) are critical for risk stratification.
Abstract:
A systematic, aggressive approach to the immunocompromised child with interstitial pneumonitis has been used in 24 consecutive patients. Parent and physician awareness of early symptoms and signs had been emphasized. When laboratory data confirmed clinical suspicion, open lung biopsy was done and lung tissue was studied by impression smears, sections, and culture techniques. The etiologic agent was established by stained impression smears within three hours of receipt of tissue in 21 of 24 patients. Eighteen of 24 patients survived. Patients had a poor prognosis if they required ventilatory assistance (five of seven died) or had respiratory symptoms for three days or more prior to biopsy (four of 13 died). Children with solid tumors who had absolute lymphocyte counts less than 500/cu mm, had received chemotherapy and radiotherapy to the chest, and had developed Pneumocystis carinii pneumonitis had a poor outcome (all three died).